Page last updated: 2024-09-05

solifenacin succinate and Urinary Incontinence

solifenacin succinate has been researched along with Urinary Incontinence in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	35 (47.30)	29.6817
2010's	32 (43.24)	24.3611
2020's	7 (9.46)	2.80

Authors

Authors	Studies
Aydh, A; Carlin, GL; Grossmann, NC; Hajebrahimi, S; Jilch, S; Katayama, S; König, F; Laukhtina, E; Mori, K; Mostafaei, H; Pradere, B; Quhal, F; Rajwa, P; Roehrborn, CG; Salehi-Pourmehr, H; Sari Motlagh, R; Schuettfort, VM; Shariat, SF	1
Chen, H; Liu, Z; Long, Z; Wang, X; Yu, S	1
Brubaker, L; Halverson, T; Mueller, ER; Wolfe, AJ	1
Daneshpajooh, A; Karbalaiee, M; Khanjani, N; Mehrabani, M; Mehrbani, M; Sohbati, S	1
Baka-Ostrowska, M; Bolong, D; Bosman, B; Dahler, E; Davies, LN; Franco, I; Hoebeke, P; Newgreen, D; Snijder, R; Stroosma, O; Vande Walle, J; Verheggen, F	1
Agema, M; Bosman, B; Snijder, R; Stroosma, O	1
Casal Beloy, T; Casal-Beloy, I; García-González, M; García-Novoa, MA; Somoza Argibay, I	1
Abrams, P; Arlandis, S; Chapple, CR; Herschorn, S; Lee, KS; Mitcheson, D; Paireddy, A; Ridder, A; Robinson, D; Stoelzel, M; van Maanen, R	1
Choudhury, N; Drake, MJ; Gibson, W; Huang, M; MacDiarmid, S; Siddiqui, E; Stölzel, M	1
Baltogiannis, D; Dimitriadis, F; Filiponi, M; Giannakis, J; Sofikitis, N; Takenaka, A; Tsounapi, P; Zachariou, A	1
Abrams, P; Al-Shukri, S; Chapple, C; Gratzke, C; Herschorn, S; Mueller, ER; Paireddy, A; Rechberger, T; Ridder, A; Robinson, D; Stoelzel, M; van Maanen, R; Yoon, SJ	1
Barrabino Martin, R; Cozar Olmo, JM; Martin Way, DA; Puche Sanz, I; Vicente Prados, FJ	1
Gotoh, M; Hamada, T; Homma, Y; Igawa, Y; Kakizaki, H; Kobayashi, A; Kuroishi, K; Nishizawa, O; Okitsu, A; Seki, N; Takeda, M; Yamaguchi, O; Yokoyama, O; Yoshida, M	1
He, L; Li, N; Liu, B; Liu, J; Liu, L; Liu, Y; Liu, Z; Pang, R; Qin, Z; Su, T; Sun, J; Wang, Y; Wu, D; Wu, J; Xu, H; Yu, J; Yue, Z; Zang, Z; Zhang, W; Zhao, J; Zhou, J; Zhou, K; Zhou, Z	1
Abrams, P; Al-Shukri, S; Chapple, C; Gratzke, C; Herschorn, S; Mueller, ER; Rechberger, T; Robinson, D; Stoelzel, M; van Maanen, R; Yoon, SJ	1
Abrams, P; Hart, WM; Munro, V; Nazir, J; Retsa, P	1
Ahlering, TE; Liss, MA; Morales, B; Skarecky, D	1
Chang, TC; Chen, CH; Hsiao, SM; Lin, HH; Su, TC	1
Chen, Y; Liu, B; Liu, Z; Mo, Q; Wang, Y; Wu, J; Xu, H	1
Ahlering, TE; Albala, DM; Belkoff, LH; Bianco, FJ; Bradt, JS; Haas, GP; He, W; Miles, BJ; Peabody, JO	1
Chen, G; Li, Y; Liao, L	1
Ahn, H; Choi, SK; Choo, MS; Huh, KO; Kim, J; Lee, SM; Park, S; Shim, M; Song, C	1
Evatt, M; Jahan, I; Ordorica, R; Salemi, JL; Shaw, JD; Singer, C; Sullivan, KL; Vaughan, CP; Zesiewicz, TA	1
Abrams, P; Kay, R; Martina, R; Ridder, A; van Maanen, R	1
Trivedi, D	1
Athanasiou, S; Cambronero, J; Chapple, C; Drake, MJ; Esen, AA; Herholdt, C; Herschorn, S; Huang, M; MacDiarmid, S; Mitcheson, D; Saleem, T; Siddiqui, E; Stölzel, M	1
Al-Shukri, S; Barkin, J; Drake, MJ; Fianu-Jonasson, A; Grise, P; Hakimi, Z; Hemsted, C; Herschorn, S; Huang, M; MacDiarmid, S; Nazir, J; Saleem, T; Siddiqui, E; Stölzel, M	1
Sidaway, P	1
Cardozo, L; Chapple, CR; Herschorn, S; Siddiqui, E; Snijder, R	1
Besuyen, R; Bolduc, S; Bosman, B; Dahler, E; Hollestein-Havelaar, A; Newgreen, D; Rittig, S; Sawyer, W	1
Cho, WY; Chung, JM; Kang, DI; Lee, SD; Park, S; Ryu, DS	1
Choo, MS; Jung, HC; Kim, HJ; Kim, JC; Kim, YH; Lee, JB; Lee, JG; Lee, JZ; Lee, KS; Na, YG; Paick, JS; Seo, JT	1
Iannazzo, S; Pradelli, L	1
Doroshyenko, O; Fuhr, U	1
Andoh, M; Appell, RA; Fakhoury, A; Hussain, IF; Ostergard, DR; Toglia, MR	1
Bolduc, S; Hamel, M; Lamontagne, P; Lebel, S; Moore, K; Nadeau, G	1
Chernev, T; Dimitrov, R; Doganov, N; Popov, E; Slavov, Ch; Slavov, S	1
Chang, TC; Ho, CH; Huang, KH; Lin, HH; Liu, SP; Yu, HJ	1
Cody, JD; Ellis, G; Hay-Smith, EJ; Herbison, GP; Madhuvrata, P	1
Kane, RL; Ramakrishnan, R; Sainfort, F; Shamliyan, T; Wyman, JF	1
Alessandri, F; Candiani, M; Ferrero, S; Leone Roberti Maggiore, U; Origoni, M; Remorgida, V; Salvatore, S; Venturini, PL	1
Ammann, LP; Bukofzer, S; Haas, GP; He, W; Janning, SW; Zinner, NR	1
Cardozo, L; Robinson, D	2
Hsieh, M; Kershen, RT	1
Cardozo, L; Drogendijk, TE; Huang, M; Kuzmin, I; Lisec, M; Millard, R; Ridder, AM; van Vierssen Trip, O	1
Sand, PK	1
Cardozo, L; Chapple, CR; Haab, F; Kelleher, CJ; Ridder, AM	1
Cardozo, L; Chapple, C; Haab, F; Ridder, AM	1
Bolodeoku, J; Chapple, CR; Drogendijk, T; Martinez-Garcia, R; Selvaggi, L; Toozs-Hobson, P; Warnack, W; Wright, DM	1
Abrams, P; Swift, S	1
Oehlke, KJ	1
Ikeda, K; Naito, R; Okamoto, Y; Takeuchi, M; Toyoshima, A; Yonetoku, Y	1
Dmochowski, RR; Staskin, DR; Wein, AJ	1
Cardozo, L; Kelleher, C; Kobashi, K; Lucente, V	1
Jonas, U; Rackley, RR	1
Simpson, D; Wagstaff, AJ	1
Serels, S	1
Hashim, H	1
Halaska, M; Millard, RJ	1
Payne, CK	1
Hussar, DA	1
MacDiarmid, SA; Staskin, DR	1
Appell, RA; McCrery, RJ; Smith, PP	1
Cardozo, L; Castro-Diaz, D; Gittelman, M; Huang, M; Ridder, A	1
Staskin, DR; Te, AE	1
Sieber, P; Wagg, A; Wyndaele, JJ	1
Goepel, M	1
Colaço, J; Gonçalves, V; Metello, J; Nogueira, B; Retto, H; Torgal, M; Vieira, A	1
Garely, AD; Lucente, V; Smith, N; Vapnek, J	1

Reviews

20 review(s) available for solifenacin succinate and Urinary Incontinence

Article	Year
Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis. European urology focus, 2022, Volume: 8, Issue:4 Topics: Benzhydryl Compounds; Humans; Muscarinic Antagonists; Network Meta-Analysis; Receptors, Adrenergic; Solifenacin Succinate; Urinary Bladder, Overactive; Urinary Incontinence	2022
Effect of Acupuncture for Mixed Urinary Incontinence in Women: A Systematic Review. Frontiers in public health, 2022, Volume: 10 Topics: Acupuncture Therapy; Female; Humans; Quality of Life; Randomized Controlled Trials as Topic; Solifenacin Succinate; Urinary Incontinence	2022
Cochrane Review Summary: Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women. Primary health care research & development, 2015, Volume: 16, Issue:6 Topics: Clenbuterol; Combined Modality Therapy; Duloxetine Hydrochloride; Electric Stimulation; Exercise Therapy; Female; Hot Temperature; Humans; Mandelic Acids; Patient Satisfaction; Pelvic Floor; Solifenacin Succinate; Treatment Outcome; Urinary Incontinence; Urological Agents	2015
Does BMI, gender or age affect efficacy/tolerability of solifenacin in the management of overactive bladder? International urogynecology journal, 2017, Volume: 28, Issue:3 Topics: Age Factors; Body Mass Index; Female; Humans; Male; Muscarinic Antagonists; Randomized Controlled Trials as Topic; Sex Factors; Solifenacin Succinate; Urinary Bladder, Overactive; Urinary Incontinence	2017
Clinical pharmacokinetics and pharmacodynamics of solifenacin. Clinical pharmacokinetics, 2009, Volume: 48, Issue:5 Topics: Animals; Clinical Trials as Topic; Humans; Protein Binding; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence	2009
Which anticholinergic drug for overactive bladder symptoms in adults. The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1 Topics: Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence	2012
Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review. Annals of internal medicine, 2012, Jun-19, Volume: 156, Issue:12 Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Comparative Effectiveness Research; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence	2012
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:11 Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Chronic Disease; Cresols; Drug Combinations; Female; Humans; Imidazoles; Mandelic Acids; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence	2012
The emerging role of solifenacin in the treatment of overactive bladder. Expert opinion on investigational drugs, 2004, Volume: 13, Issue:10 Topics: Clinical Trials as Topic; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence	2004
Preview of new drugs for overactive bladder and incontinence: darifenacin, solifenacin, trospium, and duloxetine. Current urology reports, 2004, Volume: 5, Issue:5 Topics: Benzilates; Benzofurans; Clinical Trials as Topic; Duloxetine Hydrochloride; Humans; Muscarinic Antagonists; Nortropanes; Pyrrolidines; Quinuclidines; Selective Serotonin Reuptake Inhibitors; Solifenacin Succinate; Tetrahydroisoquinolines; Thiophenes; Urinary Incontinence	2004
Elevating our therapeutic expectations in overactive bladder. Journal of the American Academy of Nurse Practitioners, 2004, Volume: 16, Issue:10 Suppl Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Constipation; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia	2004
Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU international, 2005, Volume: 95, Issue:1 Topics: Adult; Double-Blind Method; Female; Humans; Interpersonal Relations; Male; Multicenter Studies as Topic; Muscarinic Antagonists; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence	2005
Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. European urology, 2005, Volume: 48, Issue:3 Topics: Adult; Clinical Trials, Phase III as Topic; Female; Humans; Male; Middle Aged; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence	2005
Solifenacin in the management of the overactive bladder syndrome. International journal of clinical practice, 2005, Volume: 59, Issue:10 Topics: Clinical Trials as Topic; Humans; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence; Urination Disorders	2005
Solifenacin in overactive bladder syndrome. Drugs & aging, 2005, Volume: 22, Issue:12 Topics: Humans; Muscarinic Antagonists; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence	2005
Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis. Current medical research and opinion, 2006, Volume: 22, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Placebos; Population; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence	2006
Solifenacin in overactive bladder syndrome. Drugs, 2006, Volume: 66, Issue:2 Topics: Animals; Antimutagenic Agents; Clinical Trials as Topic; Humans; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence	2006
Using anticholinergics to treat overactive bladder: the issue of treatment tolerability. The American journal of medicine, 2006, Volume: 119, Issue:3 Suppl 1 Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence	2006
The emergence of new drugs for overactive bladder. Expert opinion on emerging drugs, 2006, Volume: 11, Issue:1 Topics: Acetylcholine; Amines; Animals; Anticonvulsants; Benzhydryl Compounds; Cresols; Cyclohexanecarboxylic Acids; Drug Evaluation, Preclinical; Gabapentin; gamma-Aminobutyric Acid; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Product Surveillance, Postmarketing; Quinuclidines; Randomized Controlled Trials as Topic; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence	2006
Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. The American journal of geriatric pharmacotherapy, 2006, Volume: 4, Issue:1 Topics: Aged; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Muscarinic Antagonists; Quinuclidines; Randomized Controlled Trials as Topic; Retrospective Studies; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence	2006

Trials

32 trial(s) available for solifenacin succinate and Urinary Incontinence

Article	Year
Efficacy of frankincense-based herbal product in urinary incontinence: A randomized, double-blind, placebo- and active-controlled clinical trial. Phytotherapy research : PTR, 2023, Volume: 37, Issue:5 Topics: Boswellia; Double-Blind Method; Female; Frankincense; Humans; Quality of Life; Solifenacin Succinate; Treatment Outcome; Urinary Incontinence	2023
Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies. Journal of pediatric urology, 2020, Volume: 16, Issue:2 Topics: Adult; Child; Humans; Muscarinic Antagonists; Prospective Studies; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence	2020
Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin: post hoc analysis of a phase 3 randomised clinical trial. European journal of pediatrics, 2020, Volume: 179, Issue:10 Topics: Child; Double-Blind Method; Humans; Muscarinic Antagonists; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination	2020
Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study). BJU international, 2017, Volume: 120, Issue:4 Topics: Acetanilides; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Internationality; Male; Maximum Tolerated Dose; Middle Aged; Multivariate Analysis; Risk Assessment; Single-Blind Method; Solifenacin Succinate; Thiazoles; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2017
Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study. European urology focus, 2017, Volume: 3, Issue:6 Topics: Acetanilides; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Muscarinic Antagonists; Single-Blind Method; Solifenacin Succinate; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents	2017
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). European urology, 2018, Volume: 74, Issue:4 Topics: Acetanilides; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Solifenacin Succinate; Symptom Assessment; Thiazoles; Time; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents	2018
Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study). International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:3 Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Aged, 80 and over; Benzilates; Blood Pressure; Constipation; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imidazoles; Japan; Male; Middle Aged; Muscarinic Antagonists; Nasopharyngitis; Severity of Illness Index; Solifenacin Succinate; Thiazoles; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Xerostomia	2019
Electroacupuncture Versus Pelvic Floor Muscle Training Plus Solifenacin for Women With Mixed Urinary Incontinence: A Randomized Noninferiority Trial. Mayo Clinic proceedings, 2019, Volume: 94, Issue:1 Topics: Adult; Aged; Electroacupuncture; Exercise Therapy; Female; Follow-Up Studies; Humans; Middle Aged; Pelvic Floor; Quality of Life; Solifenacin Succinate; Treatment Outcome; Urinary Incontinence; Urological Agents	2019
Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study. Neurourology and urodynamics, 2019, Volume: 38, Issue:2 Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Solifenacin Succinate; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urological Agents; Young Adult	2019
Phase 1 clinical trial of Vesicare™ (solifenacin) in the treatment of urinary incontinence after radical prostatectomy. Journal of endourology, 2014, Volume: 28, Issue:10 Topics: Aged; Humans; Male; Middle Aged; Muscarinic Antagonists; Pilot Projects; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Quinuclidines; Robotic Surgical Procedures; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence	2014
Effect of electroacupuncture versus pelvic floor muscle training plus solifenacin for moderate and severe mixed urinary incontinence in women: a study protocol. BMC complementary and alternative medicine, 2014, Aug-15, Volume: 14 Topics: Adult; Aged; Clinical Protocols; Electroacupuncture; Exercise Therapy; Female; Humans; Middle Aged; Muscle Strength; Pelvic Floor; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence	2014
A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomy. The Journal of urology, 2015, Volume: 193, Issue:4 Topics: Adult; Aged; Double-Blind Method; Humans; Male; Middle Aged; Muscarinic Antagonists; Prostatectomy; Quinuclidines; Robotic Surgical Procedures; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence	2015
The possible role of percutaneous tibial nerve stimulation using adhesive skin surface electrodes in patients with neurogenic detrusor overactivity secondary to spinal cord injury. International urology and nephrology, 2015, Volume: 47, Issue:3 Topics: Adult; Cervical Vertebrae; Electrodes; Female; Humans; Lumbar Vertebrae; Male; Muscarinic Antagonists; Quality of Life; Solifenacin Succinate; Spinal Cord Injuries; Surveys and Questionnaires; Thoracic Vertebrae; Tibial Nerve; Transcutaneous Electric Nerve Stimulation; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence	2015
The therapeutic effect of solifenacin succinate on the recovery from voiding dysfunction after radical prostatectomy in men with clinically localized prostate cancer: a prospective, randomized, controlled study. Urology, 2015, Volume: 85, Issue:5 Topics: Adrenergic alpha-1 Receptor Agonists; Aged; Drug Therapy, Combination; Humans; Male; Midodrine; Muscarinic Antagonists; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Quinuclidines; Recovery of Function; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence	2015
Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease. Parkinsonism & related disorders, 2015, Volume: 21, Issue:5 Topics: Double-Blind Method; Female; Humans; Male; Parkinson Disease; Pilot Projects; Solifenacin Succinate; Urinary Bladder, Overactive; Urinary Incontinence; Urological Agents	2015
A clinical perspective on the analysis and presentation of the number of incontinence episodes following treatment for OAB. Neurourology and urodynamics, 2016, Volume: 35, Issue:6 Topics: Acetanilides; Humans; Solifenacin Succinate; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urological Agents	2016
Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE). European urology, 2016, Volume: 70, Issue:1 Topics: Acetanilides; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retreatment; Solifenacin Succinate; Thiazoles; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents	2016
Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected]. The Journal of urology, 2016, Volume: 196, Issue:3 Topics: Acetanilides; Adolescent; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Solifenacin Succinate; Thiazoles; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics; Young Adult	2016
Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial. European urology, 2017, Volume: 71, Issue:3 Topics: Adolescent; Child; Child, Preschool; Constipation; Double-Blind Method; Female; Humans; Male; Muscarinic Antagonists; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Xerostomia	2017
Efficacy and Tolerability of Solifenacin 5 mg Fixed Dose in Korean Children with Newly Diagnosed Idiopathic Overactive Bladder: a Multicenter Prospective Study. Journal of Korean medical science, 2017, Volume: 32, Issue:2 Topics: Asian People; Child; Child, Preschool; Drug Tolerance; Fatigue; Female; Humans; Male; Prospective Studies; Republic of Korea; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents; Xerostomia	2017
Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study. International journal of clinical practice, 2008, Volume: 62, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Patient Satisfaction; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urinary Retention	2008
Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status. International urogynecology journal, 2010, Volume: 21, Issue:7 Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence	2010
Prospective open label study of solifenacin for overactive bladder in children. The Journal of urology, 2010, Volume: 184, Issue:4 Suppl Topics: Child; Female; Humans; Male; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence	2010
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms. Journal of the Formosan Medical Association = Taiwan yi zhi, 2010, Volume: 109, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Taiwan; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination	2010
Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. The Journal of urology, 2004, Volume: 172, Issue:5 Pt 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Humans; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence	2004
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome. European urology, 2005, Volume: 47, Issue:3 Topics: Constipation; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Patient Satisfaction; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia	2005
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. European urology, 2005, Volume: 48, Issue:3 Topics: Analysis of Variance; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence	2005
Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence. International urogynecology journal and pelvic floor dysfunction, 2006, Volume: 17, Issue:4 Topics: Aged; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2006
Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin. International urogynecology journal and pelvic floor dysfunction, 2006, Volume: 17, Issue:5 Topics: Adult; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Muscarinic Antagonists; Population; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2006
Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence. BJU international, 2006, Volume: 97, Issue:6 Topics: Adolescent; Adult; Aged; Cholinergic Antagonists; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence; Urodynamics	2006
Comparison of the efficacy and tolerability of solifenacin succinate with or without previous use of trospium chloride. International urogynecology journal and pelvic floor dysfunction, 2007, Volume: 18, Issue:9 Topics: Aged; Analgesics; Benzilates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Muscarinic Antagonists; Nortropanes; Prospective Studies; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2007
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Constipation; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Visual Acuity; Xerostomia	2007

Other Studies

22 other study(ies) available for solifenacin succinate and Urinary Incontinence

Article	Year
Urobiome changes differ based on OAB treatment in adult females. International urogynecology journal, 2023, Volume: 34, Issue:6 Topics: Acetanilides; Adult; Drug Therapy, Combination; Female; Humans; Muscarinic Antagonists; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2023
[Sacral electrical neurostimulation in the refractory pediatric overactive bladder]. Anales del sistema sanitario de Navarra, 2020, Dec-22, Volume: 43, Issue:3 Topics: Child; Electric Stimulation Therapy; Humans; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2020
Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron. The Canadian journal of urology, 2017, Volume: 24, Issue:6 Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Antidiuretic Agents; Deamino Arginine Vasopressin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscarinic Antagonists; Retreatment; Solifenacin Succinate; Thiazoles; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence; Urination	2017
The Effect of Anticholinergics for Prevention of Storage Symptoms After Prostate Photovaporization. Urology journal, 2019, 12-24, Volume: 16, Issue:6 Topics: Administration, Oral; Aged; Follow-Up Studies; Humans; Laser Coagulation; Male; Middle Aged; Muscarinic Antagonists; Postoperative Complications; Prostatic Hyperplasia; Quality of Life; Retrospective Studies; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Treatment Outcome; Urinary Incontinence	2019
Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom. Journal of medical economics, 2013, Volume: 16, Issue:10 Topics: Benzhydryl Compounds; Cohort Studies; Cost-Benefit Analysis; Cresols; Humans; Incontinence Pads; Mandelic Acids; Markov Chains; Medication Adherence; Models, Economic; Muscarinic Antagonists; Patient Dropouts; Phenylpropanolamine; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urinary Incontinence	2013
Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects. Maturitas, 2014, Volume: 79, Issue:1 Topics: Adult; Ankle Brachial Index; Blood Pressure; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Middle Aged; Muscarinic Antagonists; Nocturia; Pressure; Solifenacin Succinate; Tolterodine Tartrate; Urethra; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urodynamics; Vascular Stiffness	2014
Incontinence: Adding mirabegron to solifenacin improves patient outcomes. Nature reviews. Urology, 2016, Volume: 13, Issue:6 Topics: Acetanilides; Humans; Solifenacin Succinate; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2016
Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluation. Journal of medical economics, 2009, Volume: 12, Issue:1 Topics: Benzhydryl Compounds; Computer Simulation; Cost-Benefit Analysis; Cresols; Humans; Italy; Markov Chains; Muscarinic Antagonists; Pharmacogenetics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence	2009
[Solifenacin in treatment of the overactive bladder syndrome--diagnosis, clinical management and results]. Akusherstvo i ginekologiia, 2010, Volume: 49, Issue:3 Topics: Aged; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence	2010
Finding unrecognized information in overactive bladder clinical trial data: a new approach to understanding placebo and treatment effects. Neurourology and urodynamics, 2013, Volume: 32, Issue:4 Topics: Clinical Trials as Topic; Forecasting; Humans; Logistic Models; Models, Biological; Muscarinic Antagonists; Placebo Effect; Placebos; Quinuclidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sample Size; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2013
[In overactive bladder, above all urgency is stressful. The patients know the site of each toilet]. MMW Fortschritte der Medizin, 2004, May-27, Volume: 146, Issue:22 Topics: Cholinergic Antagonists; Humans; Placebos; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Time Factors; Urinary Incontinence; Urination Disorders	2004
[Overactive bladder. New anticholinergic drug controls urinary urge]. MMW Fortschritte der Medizin, 2004, Jul-08, Volume: 146, Issue:27-28 Topics: Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence; Urodynamics	2004
Solifenacin and darifenacin for overactive bladder. The Medical letter on drugs and therapeutics, 2005, Mar-14, Volume: 47, Issue:1204 Topics: Benzofurans; Drug Interactions; Humans; Intestinal Obstruction; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence; Xerostomia	2005
New treatment options for overactive bladder. South Dakota journal of medicine, 2005, Volume: 58, Issue:6 Topics: Benzofurans; Clinical Trials as Topic; Humans; Muscarinic Antagonists; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence	2005
Solifenacin and darifenacin for overactive bladder. Obstetrics and gynecology, 2005, Volume: 106, Issue:2 Topics: Benzofurans; Drug Interactions; Humans; Muscarinic Antagonists; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence	2005
Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists. Journal of medicinal chemistry, 2005, Oct-20, Volume: 48, Issue:21 Topics: Animals; Female; Models, Molecular; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Quinuclidines; Radioligand Assay; Rats; Rats, Wistar; Receptor, Muscarinic M3; Saliva; Solifenacin Succinate; Stereoisomerism; Structure-Activity Relationship; Tetrahydroisoquinolines; Urinary Bladder; Urinary Incontinence	2005
Solifenacin versus tolterodine--a head-to-head study: finally! But not final? Current urology reports, 2005, Volume: 6, Issue:6 Topics: Benzhydryl Compounds; Cresols; Double-Blind Method; Humans; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence	2005
Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome European urology, 2006, Volume: 49, Issue:1 Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence	2006
Solifenacin in overactive bladder syndrome: a viewpoint by Scott Serels. Drugs & aging, 2005, Volume: 22, Issue:12 Topics: Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence	2005
Solifenacin in overactive bladder: a viewpoint by Hashim Hashim. Drugs & aging, 2005, Volume: 22, Issue:12 Topics: Animals; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence	2005
New drugs 06, part I. Nursing, 2006, Volume: 36, Issue:2 Topics: Acamprosate; Adenine Nucleotides; Alcohol Deterrents; Amyloid; Analgesics, Non-Narcotic; Anti-HIV Agents; Antifungal Agents; Antineoplastic Agents; Aptamers, Nucleotide; Arabinonucleosides; Azabicyclo Compounds; Benzofurans; Clofarabine; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Exenatide; Fibroblast Growth Factor 7; Guanine; Humans; Hypoglycemic Agents; Islet Amyloid Polypeptide; Lipopeptides; Lipoproteins; Macular Degeneration; Micafungin; omega-Conotoxins; Patient Education as Topic; Peptides; Peptides, Cyclic; Piperazines; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Stomatitis; Taurine; Tetrahydroisoquinolines; Urinary Incontinence; Venoms	2006
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder]. Der Urologe. Ausg. A, 2006, Volume: 45, Issue:7 Topics: Analysis of Variance; Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2006